Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: Therapeutic targets to treat inflammatory and neuropathic pain

Expert Opinion on Therapeutic Targets

Volumn 11, Issue 3, 2007, Pages 307-320

  Ma, Weiya ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Neuropathic pain; Nociception; Thermal hyperalgesia; TRPV1

Indexed keywords

ADENOSINE; ANANDAMIDE; BRADYKININ; CAPSAICIN; CATION CHANNEL; ENDOCANNABINOID; ENDOTHELIN 1; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; HISTAMINE; LIPOXYGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MU OPIATE RECEPTOR; NERVE GROWTH FACTOR; NEUROTRANSMITTER; OMEGA 3 FATTY ACID; PROKINETICIN; PROLACTIN; PROTEIN DERIVATIVE; PROTEIN KINASE; PROTEINASE; PROTON; RECEPTOR BLOCKING AGENT; SEROTONIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANTINOCICEPTION; CHRONIC PAIN; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; HEAT STRESS; HUMAN; HYPERALGESIA; INFLAMMATION; MODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PATHOGENESIS; PROTEIN PHOSPHORYLATION; REVIEW; STIMULUS RESPONSE;

ANIMALS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPIDS; NEURALGIA; NEUROTRANSMITTER AGENTS; PEPTIDE HYDROLASES; PROLACTIN; TRPV CATION CHANNELS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847104189     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.11.3.307     Document Type: Review

References (118)

1. BHAVE G, GEREAU RW: Posttranslational mechanisms of peripheral sensitization. J. Neurobiol. (2004) 61:88-106.
2. CATERINA MJ, SCHUMACHER MA, TOMINAGA M, ROSEN TA, LEVINE JD, JULIUS D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 389:816-824.
3. VAN DER STELT M, DI MARZO V: Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur. J. Biochem. (2004) 271:1827-1834.
4. AHERN GP, WANG X, MIYARES RL: Polyamines are potent ligands for the capsaicin receptor TRPV1. J. Biol. Chem. (2006) 281:8991-8995.
5. CATERINA MJ, LEFFLER A, MALMBERG AB et al.: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 288:306-313.
6. AMAYA F, SHIMOSATO G, NAGANO M et al.: NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur. J. Neurosci. (2004) 20:2303-2310.
7. HUDSON LJ, BEVAN S, WOTHERSPOON G, GENTRY C, FOX A, WINTER J: VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci. (2001) 13:2105-2114.
8. MA W, ZHANG Y, BANTEL C, EISENACH JC: Medium and large injured dorsal root ganglion cells increase TRPV-1, accompanied by increased α2C-adrenoceptor co-expression and functional inhibition by clonidine. Pain (2005) 113:386-394.
9. CATERINA MJ: Vanilloid receptors take a TRP beyond the sensory afferent. Pain (2003) 105:5-9.
10. MEZEY E, TOTH ZE, CORTRIGHT DN et al.: Distribution of mRNA for vanilloid receptor subtype I(VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. USA (2000) 97:3655-3660.
11. BHAVE G, ZHU W, WANG H, BRASIER DJ, OXFORD GS, GEREAU RW: cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron (2002) 35:721-731.
12. PREMKUMAR LS, AHERN GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature (2000) 408:985-990.
13. 2+/calmodulin-dependent kinase II regulates its vanilloid binding. J. Biol. Chem. (2004) 279:7048-7054.
14. ZHUANG ZY, XU H, CLAPHAM DE, JI RR: Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J. Neurosci. (2004) 24:8300-8309.
15. LINDSAY RM: Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview. Philos. Trans. R. Soc. Lond. B Biol. Sci. (1996) 351:365-373.
16. CROWLEY C, SPENCER SD, NISHIMURA MC et al.: Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 76:1001-1011.
17. SILOS-SANTIAGO I, MOLLIVER DC, OZAKI S et al.: Non-trkA-expressing small DRG neurons are lost in trkA deficient mice. J. Neurosci. (1995) 15:5929-5942.
18. VEGA JA, GARCIA-SUAREZ O, HANNESTAD J, PEREZ-PEREZ M, GERMANA A: Neurotrophins and the immune system. J. Anat. (2003) 203:1-19.
19. MCMAHON SB: NGF as a mediator of inflammatory pain. Philos. Trans. R. Soc. Lond. [Biol.] (1996) 351:431-440.
20. WESKAMP G, OTTEN U: An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem. (1987) 48:1779-1786.
21. SHU X, MENDELL LM: Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin. Neurosci. Lett. (1999) 274:159-162.
22. SHU X, MENDELL LM: Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J. Neurophysiol. (2001) 86:2931-2938.
23. ZHANG X, HUANG J, MCNAUGHTON PA: NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J. (2005)
24. JI RR, SAMAD TA, JIN SX, SCHMOLL R, WOOLF CJ: p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron (2002) 36:57-68.
25. MOLLIVER DC, SNIDER WD: Nerve growth factor receptor TrkA is down-regulated during postnatal development by a subset of dorsal root ganglion neurons. J. Comp. Neurol. (1997) 381:428-438.
26. MALIN SA, MOLLIVER DC, KOERBER HR et al.: Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. J. Neurorci. (2006) 26:8588-8599.
27. ELITT CM, MCILWRATH SL, LAWSON JJ et al.: Artemin overexpression in skin enhances expression of TRPV1 and TRPA1 in cutaneous sensory neurons and leads to behavioral sensitivity to heat and cold. J. Neurosci. (2006) 26:8578-8587.
28. ANAND U, OTTO WR, CASULA MA et al.: The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons. Neurosci. Lett. (2006) 399:51-56.
29. WILSON-GERWING TD, DMYTERKO MV, ZOCHODNE DW, JOHNSTON JM, VERGE VM: Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons. J. Neurosci. (2005) 25:758-767.
30. RABINOVSKY ED: The multifunctional role of IGF-1 in peripheral nerve regeneration. Neurol. Res. (2004) 26:204-210.
31. RECIO-PINTO E, RECHLER MM, ISHII DN: Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. J. Neurosci. (1986) 6:1211-1219.
32. VAN BUREN JJ, BHAT S, ROTELLO R, PAUZA ME, PREMKUMAR LS: Sensitization and translocation of TRPV1 by insulin and IGF-I. Mol. Pain (2005) 1:17.
33. ISHII DN, LUPIEN SB: Insulin-like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats. J. Neurosci. Res. (1995) 40:138-144.
34. MIGDALIS IN, KALOGEROPOULOU K, KALANTZIS L, NOUNOPOULOS C, BOULOUKOS A, SAMARTZIS M: Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy. Diabet. Med. (1995) 12:823-827.
35. HONG S, WILEY JW: Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. J. Biol. Chem. (2005) 280:618-627.
36. BHAVE G, KARIM F, CARLTON SM, GEREAU RW: Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat. Neurosci. (2001) 4:417-423.
37. WALKER K, REEVE A, BOWES M et al.: mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology (2001) 40:10-19.
38. HU HJ, BHAVE G, GEREAU RW: Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. J. Neurosci. (2002) 22:7444-7452.
39. ABBOTT FV, HONG Y, BLIER P: Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology (1996) 35:99-110.
40. HONG Y, ABBOTT FV: Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience (1994) 63:827-836.
41. + channels. J. Neurophysiol. (2001) 86:241-248.
42. SUGIUAR T, BIELEFELDT K, GEBHART GF: TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation. J. Neurosci. (2004) 24:9521-9530.
43. SIMONETTI M, FABBRO A, D'ARCO M et al.: Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin. Mol. Pain (2006) 2:11.
44. OHTA T, IKEMI Y, MURAKAMI M, IMAGAWA T, OTSUGURO K, ITO S: Potentiation of transient receptor potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons. J. Physiol. (2006) 576:809-822.
45. SAWYNOK J, SWEENEY MI: The role of purines in nociception. Neuroscience (1989) 32:557-569.
46. CHEN CC, AKOPIAN AN, SIVILOTTI L, COLQUHOUN D, BURNSTOCK G, WOOD JN: A P2X purinoceptor expressed by a subset of sensory neurons. Nature (1995) 377:428-431.
47. MOLLIVER DC, COOK SP, CARLSTEN JA, WRIGHT DE, MCCLESKEY EW: ATP and UTP excite sensory neurons and induce CREB phosphorylation through the metabotropic receptor, P2Y2. Eur. J. Neurosci. (2002) 16:1850-1860.
48. TOMINAGA M, WADA M, MASU M: Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl. Acad. Sci. USA (2001) 98:6951-6956.
49. MORIYAMA T, IIDA T, KOBAYASHI K et al.: Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J. Neurosci. (2003) 23:6058-6062.
50. LAKSHMI S, JOSHI PG: Co-activation of P2Y2 receptor and TRPV channel by ATP: implications for ATP induced pain. Cell Mol. Neurobiol. (2005) 25:819-832.
51. SUZUKI T, NAMBA K, TSUGA H, NAKATA H: Regulation of pharmacology by hetero-oligomerization between A1 adenosine receptor and P2Y2 receptor. Biochem. Biophys. Res. Commun. (2006) 351:559-565.
52. SAWYNOK J: Adenosine receptor activation and nociception. Eur. J. Pharmacol. (1998) 347:1-11.
53. PUNTAMBEKAR P, VAN BUREN J, RAISINGHANI M, PREMKUMAR LS, RAMKUMAR V: Direct interaction of adenosine with the TRPV1 channel protein. J. Neurosci. (2004) 24:3663-3671.
54. 2+ influx via the PLA(2)/lipoxygenase/TRPV1 pathway in rat sensory neurons. Neurosci. Lett. (2004) 361:159-162.
55. MARCEAU F, REGOLI D: Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug Discov. (2004) 3:845-852.
56. CAMPOS MM, LEAL PC, YUNES RA, CALIXTO JB: Non-peptide antagonists for kinin B(1) receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol. Sci. (2006) 27:646-651.
57. CALIXTO JB, CABRINI DA, FERREIRA J, CAMPOS MM: Kinins in pain and inflammation. Pain (2000) 87:1-5.
58. CHUANG HH, PRESCOTT ED, KONG H et al.: Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature (2001) 411:957-962.
59. FERREIRA J, DA SILVA GL, CALIXTO JB: Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br. J. Pharmacol. (2004) 141:787-794.
60. TANG HB, INOUE A, OSHITA K, NAKATA Y: Sensitization of vanilloid receptor 1 induced by bradykinin via the activation of second messenger signaling cascades in rat primary afferent neurons. Eur. J. Pharmacol. (2004) 498:37-43.
61. MOLLAY C, WECHSELBERGER C, MIGNOGNA G et al.: Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur. J. Pharmacol. (1999) 374:189-196.
62. VELLANI V, COLUCCI M, LATTANZI R et al.: Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8. J. Neurosci. (2006) 26:5109-5116.
63. NEGRI L, LATTANZI R, GIANNINI E et al.: Nociceptive sensitization by the secretory protein Bv8. Br. J. Pharmacol. (2002) 137:1147-1154.
64. LECOUTER J, ZLOT C, TEJADA M, PEALE F, FERRARA N: Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc. Natl. Acad. Sci. USA (2004) 101:16813-16818.
65. MARTUCCI C, FRANCHI S, GIANNINI E et al.: Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br. J. Pharmacol.. (2006) 147:225-234.
66. NEGRI L, LATTANZI R, GIANNINI E et al.: Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J. Neurosci. (2006) 26:6716-6727.
67. NICOL GD: ET-phone the pain clinic. Trends Neurosci. (2004) 27:177-180.
68. DYMSHITZ J, VASKO MR: Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons. Neurosci. Lett. (1994) 167:128-132.
69. PLANT TD, ZOLLNER C, MOUSA SA, OKSCHE A: Endothelin-1 potentiates capsaicin-induced TRPV1 currents via the endothelin A receptor. Exp. Biol. Med. (Maywood) (2006) 231:1161-1164.
70. BALONOV K, KHODOROVA A, STRICHARTZ GR: Tactile allodynia initiated by local subcutaneous endothelin-1 is prolonged by activation of TRPV-1 receptors. Exp. Biol. Med. (Maywood) (2006) 231:1165-1170.
71. MATTHES HW, MALDONADO R, SIMONIN F et al.: Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the opioid-receptor gene. Nature (1996) 383:819-823.
72. VETTER I, WYSE BD, MONTEITH GR, ROBERTS-THOMSON SJ, CABOT PJ: The opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway. Mol. Pain (2006) 2:22.
73. ENDRES-BECKER J, HEPPENSTALL PA, MOUSA SA et al.: receptor activation modulate TRPV1 currents in sensory neurons in a model of inflammatory pain. Mol. Pharmacol. (2006) Epub ahead of print:
74. AMAYA F, OH-HASHI K, NARUSE Y et al.: Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res. (2003) 963:190-196.
75. DIOGENES A, PATWARDHAN AM, JESKE NA et al.: Prolactin modulates TRPV1 in female rat trigeminal sensory neurons. J. Neurosci. (2006) 26:8126-8136.
76. RICE AS, FARQUHAR-SMITH WP, NAGY I: Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot. Essent. Fatty Acids (2002) 66:243-256.
77. PATWARDHAN AM, JESKE NA, PRICE TJ, GAMPER N, AKOPIAN AN, HARGREAVES KM: The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc. Natl. Acad. Sci. USA (2006) 103:11393-11398.
78. JESKE NA, PATWARDHAN AM, GAMPER N, PRICE TJ, AKOPIAN AN, HARGREAVES KM: Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J. Biol. Chem. (2006) 281:32879-32890,
79. PIOMELLI D: The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. (2003) 4:873-884.
80. VAN DER STELT M, DI MARZO V: Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat. (2005) 77:111-122.
81. ZYGMUNT PM, PETERSSON J, ANDERSSON DA et al.: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 400:452-457.
82. DE PETROCELLIS L, BISOGNO T, MACCARRONE M, DAVIS JB, FINAZZI-AGRO A, DI MARZO V: The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. (2001) 276:12856-12863.
83. DINIS P, CHARRUA A, AVELINO A et al.: Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J. Neurosci. (2004) 24:11253-11263.
84. SINGH TA, SANTHA P, NAGY I: Inflammatory mediators convert anandamide into a potent activator of the vanilloid Type 1 transient receptor potential receptor in nociceptive primary sensory neurons. Neuroscience (2005) 136:539-548.
85. AHLUWALIA J, YAQOOB M, URBAN L, BEVAN S, NAGY I: Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J. Neurochem. (2003) 84:585-591.
86. 2+ influx via TRPV1 channels. EMBO J. (2005) 24:3026-3037.
87. SAMUELSSON B: Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science (1983) 220:568-575.
88. LEVINE JD, LAU W, KWIAT G, GOETZL EJ: Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science (1984) 225:743-745.
89. HWANG SW, CHO H, KWAK J et al.: Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. USA (2000) 97:6155-6160.
90. SHIN J, CHO H, HWANG SW et al.: Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA (2002) 99:10150-10155.
91. VANEGAS H, SCHAIBLE HG: Prostaglandins and cycloxygenases in the spinal cord. Prog. Neurobiol. (2001) 64:327-363.
92. CLAUDINO RF, KASSUYA CA, FERREIRA J, CALIXTO JB: Pharmacological and molecular characterization of the mechanisms involved in prostaglandin E2-induced mouse paw edema. J. Pharmacol. Exp. Ther. (2006) 318:611-618.
93. PITCHFORD S, LEVINE JD: Prostaglandins sensitize nociceptors in cell culture. Neurosci. Lett. (199l) 132:105-108.
94. MORIYAMA T, HIGASHI T, TOGASHI K et al.: Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain (2005) 1:3-16.
95. MATTA JA, MIYARES RL, AHERN GP: TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. J. Physiol. (2006) Epub ahead of print.
96. NYSTEDT S, EMILSSON K, WAHLESTEDT C, SUNDELIN J: Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. USA (1994) 91:9208-9212.
97. DERY O, CORVERA CU, STEINHOFF M, BUNNETT NW: Proteinase-activared receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. (1998) 274:C1429-C1452.
98. VERGNOLLE N, WALLACE JL, BUNNETT NW, HOLLENBERG MD: Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol. Sci. (2001) 22:146-152.
99. STEINHOFF M, VERGNOLLE N, YOUNG SH et al.: Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. (2000) 6:151-158.
100. VERGNOLLE N, BUNNETT NW, SHARKEY KA et al.: Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat. Med. (2001) 7:821-826.
101. DAI Y, MORIYAMA T, HIGASHI T et al.: Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J. Neurosci. (2004) 24:4293-4299.
102. AMADESI S, NIEJ, VERGNOLLE N et al.: Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J. Neurosci. (2004) 24:4300-4312.
103. AMADESI S, COTTRELL GS, DIVINO L et al.: Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cε- and A-dependent mechanisms in rats and mice. J. Physiol. (2006) 575:555-571.
104. BODDEKE EW: Involvement of chemokines in pain. Eur. J. Pharmacol. (2001) 429:115-119.
105. MILLIGAN ED, ZAPATA V, CHACUR M et al.: Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur. J. Neurosci. (2004) 20:2294-2302.
106. OH SB, TRAN PB, GILLARD SE, HURLEY RW, HAMMOND DL, MILLER RJ: Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. (2001) 21:5027-5035.
107. SACHS D, CUNHA FQ, POOLE S, FERREIRA SH: Tumour necrosis factor-α, intedeukin-1β and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain (2002) 96:89-97.
108. ZHANG N, INAN S, COWAN A et al.: A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc. Natl. Acad. Sci. USA (2005) 102:4536-4541.
109. ABBADIE C, LINDIA JA, CUMISKEY AM et al.: Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. USA (2003) 100:7947-7952.
110. WHITE FA, SUN J, WATERS SM et al.: Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc. Natl. Acad. Sci. USA (2005) 102:14092-14097.
111. JUNG H, OTH T, HITE FA, ILLER RJ: The chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2) functions as a neurotransmitter in dorsal root ganglia. Soc. Neurosci. Abstr. (2006) 250.4.
112. SOMMER C, KRESS M: Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. (2004) 361:184-187.
113. NICOL GD, LOPSHIRE JC, PAFFORD CM: Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons. J. Neurosci. (1997) 17:975-982.
114. JIN X, GEREAU RW: Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-α. J. Neurosci. (2006) 26:246-255.
115. SZALLASI A, CRUZ F, GEPPETTI P: TRPV1: a therapeutic target for novel analgesic drugs? Trends Mol. Med. (2006) 12:545-554.
116. JHAVERI MD, RICHARDSON D, KENDALL DA, BARRETT DA, CHAPMAN V, Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J. Neurosci. (2006) 26:13318-13327.
117. CHEN CW, LEE ST, WU WT, FU WM, HO FM, LIN WW: Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages. Br. J. Pharmacol. (2003) 140:1077-1087.
118. LEE H, CATERINA MJ: TRPV channels as thermosensory receptors in epithelial cells. Pflugers Arch. (2005) 451:160-167.